Search results for "Thermo Fisher Scientific"

Thermo Fisher Scientific

T cell isolation and controlled release delivers flexibility and control in process development, clinical trials and commercial manufacturing

myeloMATCH precision medicine clinical trial leverages next-day genomic testing to quickly match patients with appropriate trials across North America

Guest editorial by Dale Powner, Country Manager for the UK, Ireland and Nordics at Binding Site, part of Thermo Fisher Scientific

Dr. Richard Knight, medical director of transplant diagnostics at Thermo Fisher Scientific explores personalized, non‑invasive approaches designed to improve transplant success

New partnership will unlock fully automated cell line production

Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers

Gibco™ CTS Cellmation™ Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate manufacturing

The acquisition will offer greater flow cytometry and imaging multiplexing capabilities to meet needs in protein and cell analysis research

International competition rewards top proteomics researchers for outstanding innovation and societal impact

Low-cost kits help global public health professionals quickly identify potential outbreaks

The Applied Biosystems QuantStudio Absolute Q Digital PCR System is the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes

The self-collection kits facilitate raw saliva collection to aid global SARS-CoV-2 research and surveillance efforts

Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations

The Invitrogen Attune CytPix Flow Cytometer* enables researchers and cell therapy developers to collect fluorescent data and high resolution images

The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools

Agreement aims to expedite local biomarker testing of NSCLC patients eligible for entrectinib in Japan